Ustrell V, Pratt G, Rechsteiner M
Department of Biochemistry, University of Utah School of Medicine, Salt Lake City 84132.
Proc Natl Acad Sci U S A. 1995 Jan 17;92(2):584-8. doi: 10.1073/pnas.92.2.584.
We have examined several peptidase activities of human multicatalytic protease (MCP) purified from the lymphoblastoid cell line 721.45 and a deletion mutant derivative, 721.174, lacking MCP subunits encoded in the major histocompatibility complex (MHC) class II region. Wild-type lymphoblast MCP hydrolyzed a specific peptide, glutaryl-Gly-Gly-Phe-4-methylcoumaryl-7-amide (-MCA), several times faster than the mutant enzyme did, suggesting that MHC-encoded subunits may provide this activity. Contrary to a recent report [Driscoll, J., Brown, M. G., Finley, D. & Monaco, J J. (1993) Nature (London) 365, 262-264], we did not detect significant aminopeptidase associated with lymphoblast MCPs. Our results also differ markedly from those of Gaczynska et al. [Gaczynska, M., Rock, K. L. & Goldberg, A L. (1993) Nature (London) 365, 264-267], who reported that gamma interferon (IFN-gamma) alters the peptidase activities of lymphoblast MCPs. We found that IFN-gamma did not produce significant differences in the peptidase activities of purified MCPs. Moreover, our measurements of Vmax and Km for succinyl-Leu-Leu-Val-Tyr-MCA hydrolysis differ 600-fold and 15-fold, respectively, from those reported by Gaczynska et al. On balance, the findings presented here do not support the idea that IFN-gamma induces major changes in the peptidase activity of purified MCPs.
我们检测了从淋巴母细胞系721.45中纯化得到的人多催化蛋白酶(MCP)以及一个缺失突变体衍生物721.174的几种肽酶活性。721.174缺失主要组织相容性复合体(MHC)II类区域编码的MCP亚基。野生型淋巴母细胞MCP水解特定肽段戊二酰 - 甘氨酰 - 苯丙氨酸 - 4 - 甲基香豆素 - 7 - 酰胺(-MCA)的速度比突变酶快几倍,这表明MHC编码的亚基可能提供这种活性。与最近的一份报告[德里斯科尔,J.,布朗,M.G.,芬利,D.和莫纳科,J.J.(1993年)《自然》(伦敦)365,262 - 264]相反,我们未检测到与淋巴母细胞MCP相关的显著氨肽酶活性。我们的结果也与加钦斯卡等人[加钦斯卡,M.,罗克,K.L.和戈德堡,A.L.(1993年)《自然》(伦敦)365,264 - 267]的结果明显不同,他们报告γ干扰素(IFN - γ)会改变淋巴母细胞MCP的肽酶活性。我们发现IFN - γ对纯化的MCP的肽酶活性没有产生显著差异。此外,我们对琥珀酰 - 亮氨酰 - 亮氨酰 - 缬氨酰 - 酪氨酸 - MCA水解的Vmax和Km测量值与加钦斯卡等人报告的值分别相差600倍和15倍。总体而言,此处呈现的研究结果不支持IFN - γ会诱导纯化的MCP的肽酶活性发生重大变化这一观点。